Organon & Co | OGN - Net Income

Stock Price
8.16
Daily Change
-0.38 -4.45%
Monthly
9.68%
Yearly
-45.38%
Q1 Forecast
8.28

Organon & Co reported $160M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Bristol-Myers Squibb USD 2.2B 891M Sep/2025
Celltrion KRW 331.35B 270.18B Sep/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 6.89B 1.44B Sep/2025
Gilead Sciences USD 3.05B 1.09B Sep/2025
Glaxosmithkline GBP 2.71B 1.27B Sep/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -105K 409K Jun/2025
Merck USD 5.78B 1.36B Sep/2025
Neuren Pharmaceuticals AUD 7.52M 126.51M Jun/2025
Novartis USD 3.93B 113M Sep/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Pharma Mar EUR -4.1M 27.47M Sep/2025
Qiagen NV USD 130.04M 33.79M Sep/2025
Sartorius EUR 43.8M 11.3M Sep/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tilray USD -44.93M 44.61M Sep/2025